HENRY SCHEIN INC (HSIC) Stock
11 members of Congress disclosed 20 trades in HSIC since 2014: 7 purchases and 13 sales, most recently Rob Bresnahan (purchase, Apr 8, 2025). 7 of the hedge funds AlphaScala tracks reported HSIC in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $243.97M.
Which members of Congress traded HENRY SCHEIN INC (HSIC)?
Most recent: Rob Bresnahan (purchase, Apr 8, 2025); records start Jul 23, 2014.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Rob Bresnahan R-PA · House | 2025-04-08 | purchase | $1k – $15k |
| Julie Johnson D-TX · House | 2025-04-01 | sale | $1k – $15k |
| Gil Cisneros D-CA · House | 2025-03-31 | sale | $1k – $15k |
| Peter Meijer R-MI · House | 2021-02-16 | sale | $15k – $50k |
| Lois Frankel D-FL · House | 2020-08-07 | sale | $1k – $15k |
| Greg Gianforte R-MT · House | 2019-09-12 | sale | $50k |
| David McKinley R-WV · House | 2018-12-20 | sale | $1k – $15k |
| David McKinley R-WV · House | 2018-12-17 | sale | $15k – $50k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.
See all HSIC political trades →Which hedge funds own HSIC?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 2.92M | $243.97M | +8703% |
| Greenlight Capital David Einhorn | 719K | $60.01M | +20% |
| Bridgewater Associates Ray Dalio | 59K | $4.93M | +84% |
| Marshall Wace | 38K | $3.14M | NEW |
| Point72 Steve Cohen | 37K | $3.12M | -93% |
| D.E. Shaw David Shaw | 10K | $806.2K | -69% |
| Millennium Management Israel Englander | 4K | $320.8K | -98% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →HSIC price chart
Powered by TradingViewWhat does HENRY SCHEIN INC do?
Henry Schein is a global healthcare solutions company that serves dental, medical, and veterinary practitioners through two primary business segments. The Healthcare Distribution segment supplies consumable products, small equipment, laboratory products, and vitamins to office-based practitioners and alternate care sites worldwide. The Technology and Value-Added Services segment delivers software, technology platforms, and related services that help healthcare professionals enhance operational efficiency and patient care delivery. With a portfolio of corporate and owned brands exceeding $3 billion, Henry Schein supports dental laboratories, government clinics, and institutional healthcare facilities across multiple countries. Founded in 1932 and headquartered in Melville, New York, the company operates as a comprehensive solutions provider that integrates supply chain management, clinical tools, and digital technology to optimize healthcare delivery and practice management for its diverse customer base.